Annual ROA
-51.37%
-10.71%-26.34%
31 December 2023
Summary:
Viridian Therapeutics annual return on assets is currently -51.37%, with the most recent change of -10.71% (-26.34%) on 31 December 2023. During the last 3 years, it has fallen by -3.95% (-8.33%). VRDN annual ROA is now -26.34% below its all-time high of -40.66%, reached on 31 December 2022.VRDN ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-45.79%
+1.99%+4.16%
30 September 2024
Summary:
Viridian Therapeutics quarterly return on assets is currently -45.79%, with the most recent change of +1.99% (+4.16%) on 30 September 2024. Over the past year, it has increased by +13.87% (+23.25%). VRDN quarterly ROA is now -13.96% below its all-time high of -40.18%, reached on 30 June 2018.VRDN Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRDN ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +23.3% |
| 3 y3 years | -8.3% | +8.1% |
| 5 y5 years | +40.9% | +47.7% |
VRDN ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -26.3% | at low | -1.0% | +23.3% |
| 5 y | 5 years | -26.3% | +62.5% | -1.0% | +77.9% |
| alltime | all time | -26.3% | +80.2% | -14.0% | +77.9% |
Viridian Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -45.79%(-4.2%) |
| June 2024 | - | -47.78%(-4.2%) |
| Mar 2024 | - | -49.85%(-16.4%) |
| Dec 2023 | -51.37%(+26.3%) | -59.66%(+7.0%) |
| Sept 2023 | - | -55.77%(+0.5%) |
| June 2023 | - | -55.48%(+4.0%) |
| Mar 2023 | - | -53.34%(+17.6%) |
| Dec 2022 | -40.66%(-14.3%) | -45.34%(-2.2%) |
| Sept 2022 | - | -46.38%(-15.3%) |
| June 2022 | - | -54.78%(+7.4%) |
| Mar 2022 | - | -51.02%(+2.4%) |
| Dec 2021 | -47.42%(-65.4%) | -49.81%(-55.8%) |
| Sept 2021 | - | -112.73%(-25.5%) |
| June 2021 | - | -151.23%(-10.2%) |
| Mar 2021 | - | -168.49%(-18.8%) |
| Dec 2020 | -137.09%(+57.8%) | -207.42%(+140.5%) |
| Sept 2020 | - | -86.25%(-8.3%) |
| June 2020 | - | -94.09%(+4.1%) |
| Mar 2020 | - | -90.36%(+3.1%) |
| Dec 2019 | -86.87% | -87.62%(+18.8%) |
| Sept 2019 | - | -73.75%(+21.5%) |
| June 2019 | - | -60.69%(+12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -54.12%(+20.5%) |
| Dec 2018 | -55.14%(-41.0%) | -44.91%(+7.7%) |
| Sept 2018 | - | -41.70%(+3.8%) |
| June 2018 | - | -40.18%(-2.2%) |
| Mar 2018 | - | -41.09%(-34.4%) |
| Dec 2017 | -93.45%(-36.7%) | -62.63%(-18.7%) |
| Sept 2017 | - | -77.07%(-8.6%) |
| June 2017 | - | -84.33%(-10.7%) |
| Mar 2017 | - | -94.46%(-33.6%) |
| Dec 2016 | -147.71%(+36.9%) | -142.28%(+55.4%) |
| Sept 2016 | - | -91.54%(-2.6%) |
| June 2016 | - | -93.99%(+10.5%) |
| Mar 2016 | - | -85.04%(-3.0%) |
| Dec 2015 | -107.93%(-19.6%) | -87.64%(+1.2%) |
| Sept 2015 | - | -86.58%(+8.8%) |
| June 2015 | - | -79.58%(-23.0%) |
| Mar 2015 | - | -103.31%(-7.2%) |
| Dec 2014 | -134.16%(+100.4%) | -111.30%(+30.4%) |
| Sept 2014 | - | -85.33%(-0.1%) |
| June 2014 | - | -85.44%(+31.5%) |
| Mar 2014 | - | -64.97%(+10.5%) |
| Dec 2013 | -66.94%(-74.2%) | -58.81% |
| Dec 2012 | -259.33% | - |
FAQ
- What is Viridian Therapeutics annual return on assets?
- What is the all time high annual ROA for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly ROA year-on-year change?
What is Viridian Therapeutics annual return on assets?
The current annual ROA of VRDN is -51.37%
What is the all time high annual ROA for Viridian Therapeutics?
Viridian Therapeutics all-time high annual return on assets is -40.66%
What is Viridian Therapeutics quarterly return on assets?
The current quarterly ROA of VRDN is -45.79%
What is the all time high quarterly ROA for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly return on assets is -40.18%
What is Viridian Therapeutics quarterly ROA year-on-year change?
Over the past year, VRDN quarterly return on assets has changed by +13.87% (+23.25%)